반응식
[CH3:1][S:2][C:3]1[N:8]=[C:7]([C:9]2[CH:10]=[C:11]3[CH:27]=[N:26][NH:25][C:12]3=[N:13][C:14]=2[C:15]2[CH:20]=[CH:19][CH:18]=[C:17]([C:21]([F:24])([F:23])[F:22])[CH:16]=2)[CH:6]=[CH:5][N:4]=1.Br[CH2:29][CH2:30][CH2:31][O:32][CH:33]1[CH2:38][CH2:37][CH2:36][CH2:35][O:34]1>>[CH3:1][S:2][C:3]1[N:8]=[C:7]([C:9]2[C:14]([C:15]3[CH:20]=[CH:19][CH:18]=[C:17]([C:21]([F:23])([F:22])[F:24])[CH:16]=3)=[N:13][C:12]3=[N:25][N:26]([CH2:29][CH2:30][CH2:31][O:32][CH:33]4[CH2:38][CH2:37][CH2:36][CH2:35][O:34]4)[CH:27]=[C:11]3[CH:10]=2)[CH:6]=[CH:5][N:4]=1참가 물질
3
반응물 2
생성물 1
실험 절차
Following a similar procedure to that described in examples 6 and 7, but starting from 5-[2-(methylsulfanyl)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]-1H-pyrazolo[3,4-b]pyridine (obtained in example 126) and 2-(3-bromopropoxy)tetrahydropyran, the title compound was obtained.
출처 및 근거
- ORD 기록
- ord-57193f1841a74ffb8d4227914efa1b74
- 출처 데이터셋
- uspto-grants-2013_09
- 특허 번호
- US08536194B2
연결된 노트
불러오는 중…